Get the Stockscreener App
12.06
3.25%
0.38
Ceribell Inc stock is traded at $12.06, with a volume of 365.70K.
It is up +3.25% in the last 24 hours and down -22.29% over the past month.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
See More
Previous Close:
$11.68
Open:
$11.68
24h Volume:
365.70K
Relative Volume:
1.12
Market Cap:
$442.17M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.03%
1M Performance:
-22.29%
6M Performance:
-51.15%
1Y Performance:
+0.00%
1-Day Range:
$11.61
$12.27
1-Week Range:
$11.35
$12.60
52-Week Range:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Name
Ceribell Inc
Sector
Industry
Phone
(800) 436-0826
Address
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
12.06 | 446.57M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-24-25 | Initiated | BTIG Research | Buy |
| Apr-04-25 | Initiated | Ladenburg Thalmann | Buy |
| Nov-05-24 | Initiated | BofA Securities | Buy |
| Nov-05-24 | Initiated | Canaccord Genuity | Buy |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
View All
Ceribell Inc Stock (CBLL) Latest News
Custom Dashboard Highlights CeriBell Inc. Price MomentumWall Street Watch & Reliable Price Action Trade Plans - thegnnews.com
Sector Rotation Brings CeriBell Inc. Into FocusGap Up & Technical Pattern Recognition Alerts - newsimpact.co.kr
CeriBell Inc. Ranks High in Smart Money Tracker2025 Price Targets & Consistent Profit Alerts - classian.co.kr
Will CeriBell Inc. price bounce be sustainable2025 Dividend Review & Verified Entry Point Detection - Newser
Best data tools to analyze CeriBell Inc. stockEarnings Recap Report & Free High Return Stock Watch Alerts - Newser
Will CeriBell Inc. stock recover after recent dropMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
Using RSI to spot recovery in CeriBell Inc.Market Sentiment Report & Weekly Top Performers Watchlists - Newser
CeriBell Inc. Stock Support and Resistance Levels You Should KnowOil Prices & Weekly Stock Performance Updates - Newser
What data driven models say about CeriBell Inc.’s futurePortfolio Return Report & Long-Term Safe Investment Ideas - Newser
Multi factor analysis applied to CeriBell Inc.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Is this a good reentry point in CeriBell Inc.2025 Performance Recap & Detailed Earnings Play Strategies - Newser
MACD Signals Flash Warning for CeriBell Inc. StockPortfolio Return Summary & AI Powered Buy/Sell Recommendations - sundaytimes.kr
Relief Rally in CeriBell Inc. Stock — Can It HoldQuarterly Market Summary & Community Supported Trade Ideas - beatles.ru
Applying Wyckoff theory to CeriBell Inc. stock2025 Stock Rankings & Smart Money Movement Tracker - Newser
Is CeriBell Inc. meeting your algorithmic filter criteriaQuarterly Profit Report & AI Optimized Trade Strategies - Newser
Tools to assess CeriBell Inc.’s risk profileOil Prices & Daily Momentum Trading Reports - Newser
J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT - MSN
What does recent volatility data suggest for CeriBell Inc.Market Performance Report & AI Powered Buy and Sell Recommendations - Newser
Ceribell reports Q2 EPS (38c), consensus (40c) - MSN
Ceribell alleges EEG patent infringement by Natus - BioWorld MedTech
Ceribell, Inc.: Strategic Expansion and Diversification Drive Positive Outlook - TipRanks
12 Best Medical Device Stocks to Buy According to Analysts - Insider Monkey
Intraday pattern recognizer results for CeriBell Inc.Entry Zone Watchlist With Momentum Focus - Newser
Research Analysts Set Expectations for CeriBell Q3 Earnings - Defense World
Ceribell, Inc. Reports Strong Q2 2025 Revenue Growth - TipRanks
CeriBell, Inc. (NASDAQ:CBLL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
Ceribell, Inc. Reports Strong Q2 Growth Amid Challenges - The Globe and Mail
CeriBell Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Institutional investors in CeriBell, Inc. (NASDAQ:CBLL) must be dismayed after prices dropped by 14% last week - simplywall.st
Ceribell raises FY25 revenue view to $85M-$88M from $83M-$87M - MSN
Ceribell, Inc. Faces Financial Uncertainty Amid Trade Policy Shifts and Tariff Challenges - TipRanks
CeriBell (CBLL) Q2 Revenue Jumps 38% - The Globe and Mail
Ceribell outlines $85M–$88M 2025 revenue target while expanding pediatric and neonate pilots - MSN
CeriBell Q2 2025 Earnings Call Transcript - MarketBeat
CeriBell's Q2 2025 Earnings: A Turnaround Play in a High-Stakes Neurodiagnostics Market - AInvest
Ceribell Reports Second Quarter 2025 Financial Results - The Manila Times
CeriBell 2025 Q2 Earnings Loss Narrows Despite Revenue Surge - AInvest
CeriBell Inc (CBLL): Assessing the Long-Term Value of a High-Growth, Pre-Profit Med-Tech Innovator - AInvest
CeriBell, Inc.'s Q2 2025 Earnings: Unpacking Contradictions on Margins, Market Expansion, and Growth Strategy - AInvest
Transcript : CeriBell, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: CeriBell Inc Q2 2025 shows revenue growth, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: CeriBell Inc Q2 2025 shows revenue growth, stock dips - Investing.com Canada
CeriBell Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Reversal Traders Monitor CeriBell Inc. for EntryCapital Doubling Tips - beatles.ru
How to build a custom watchlist for CeriBell Inc.Day Trading Setup Forecast with Trend Model - Newser
Published on: 2025-08-04 23:36:04 - Newser
Ceribell, Inc.: Positioned for Growth with Strong Revenue Projections and Market Expansion Opportunities - TipRanks
How strong is CeriBell Inc. company’s balance sheetCapitalize on emerging industry trends - Jammu Links News
CeriBell Inc. Stock Analysis and ForecastAchieve superior returns through strategic trading - Jammu Links News
What drives CeriBell Inc. stock priceBreakneck growth rates - Jammu Links News
Ceribell Inc Stock (CBLL) Financials Data
There is no financial data for Ceribell Inc (CBLL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Ceribell Inc Stock (CBLL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Jul 07 '25 |
Option Exercise |
2.24 |
25,000 |
56,000 |
801,222 |
| Chao Xingjuan | President and CEO |
Jul 07 '25 |
Sale |
17.70 |
25,000 |
442,500 |
776,022 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):